NDC properties for NDC 9 0093-0088
NDC item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2009-01-31 |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2009-01-31 |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
NDC item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-06-02 |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
NDC item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2012-06-02 |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
NDC item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
NDC item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-29 |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
NDC item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2018-09-30 |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 660557 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-31 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 660557 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-31 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
NDC item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 764616 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 764616 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 764616 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 764616 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
NDC item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 800133 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 800133 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
NDC item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 800133 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | active |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |